Skip to main content
Premium Trial:

Request an Annual Quote

Metamark's Cambridge Lab Receives CAP Accreditation

NEW YORK (GenomeWeb) – Metamark today announced that its Cambridge, Mass., laboratory has received accreditation from the College of American Pathologists.

The lab will be the primary facility for processing the company's ProMark protein-biopsy test to aid physicians and prostate cancer patients select the most appropriate treatment options. The test generates a score and is targeted to the 85 percent of patients with biopsy Gleason grades of 3+3 or 3+4 for whom current standard-of-care tests may offer unclear guidance, the Cambridge-based firm said.

The lab is also CLIA certified, and earlier this year Metamark's CLIA-accredited labs in Collegeville, Penn., and Augusta, Ga., also received accreditation by CAP.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.